$LSBK
LAKE SHORE BANCORP, INC.

2020 Q1 Form 10-Q Financial Statement

#000134131820000038 Filed on May 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $6.291M $5.662M
YoY Change 11.11% 10.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $210.0K $200.0K
YoY Change 5.0% 0.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.395M $1.124M
YoY Change 24.11% 44.85%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $853.0K $1.049M
YoY Change -18.68% -3.67%
Income Tax $122.0K $151.0K
% Of Pretax Income 14.3% 14.39%
Net Earnings $731.0K $898.0K
YoY Change -18.6% -4.06%
Net Earnings / Revenue 11.62% 15.86%
Basic Earnings Per Share $0.12 $0.15
Diluted Earnings Per Share $0.12 $0.15
COMMON SHARES
Basic Shares Outstanding 5.987M 6.032M
Diluted Shares Outstanding 5.987M 6.041M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $45.54M $31.11M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $9.458M $9.305M
YoY Change 1.64% 0.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $628.3M $554.5M
YoY Change 13.31% 4.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $900.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $900.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $6.300M $5.100M
YoY Change 23.53% 2.0%
Total Long-Term Liabilities $6.300M $5.100M
YoY Change 23.53% -84.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $900.0K
Total Long-Term Liabilities $6.300M $5.100M
Total Liabilities $544.5M $473.4M
YoY Change 15.01% 4.77%
SHAREHOLDERS EQUITY
Retained Earnings $62.42M $59.77M
YoY Change 4.44%
Common Stock $31.17M $31.02M
YoY Change 0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.37M $8.867M
YoY Change 16.89%
Treasury Stock Shares $918.2K $825.2K
Shareholders Equity $83.83M $81.06M
YoY Change
Total Liabilities & Shareholders Equity $628.3M $554.5M
YoY Change 13.31% 4.6%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $731.0K $898.0K
YoY Change -18.6% -4.06%
Depreciation, Depletion And Amortization $210.0K $200.0K
YoY Change 5.0% 0.0%
Cash From Operating Activities $1.386M $303.0K
YoY Change 357.43% -36.61%
INVESTING ACTIVITIES
Capital Expenditures $253.0K $86.00K
YoY Change 194.19% -42.67%
Acquisitions
YoY Change
Other Investing Activities -$2.070M -$6.690M
YoY Change -69.06% 35.43%
Cash From Investing Activities -$2.319M -$6.780M
YoY Change -65.8% 33.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $377.0K $111.0K
YoY Change 239.64% -66.26%
Debt Paid & Issued, Net $1.200M $750.0K
YoY Change 60.0% -50.0%
Cash From Financing Activities 16.18M 6.832M
YoY Change 136.87% -39.21%
NET CHANGE
Cash From Operating Activities 1.386M 303.0K
Cash From Investing Activities -2.319M -6.780M
Cash From Financing Activities 16.18M 6.832M
Net Change In Cash 15.25M 355.0K
YoY Change 4195.77% -94.64%
FREE CASH FLOW
Cash From Operating Activities $1.386M $303.0K
Capital Expenditures $253.0K $86.00K
Free Cash Flow $1.133M $217.0K
YoY Change 422.12% -33.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei City Area Code
CityAreaCode
716
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
31 East Fourth Street
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dunkirk
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14048
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001341318
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5886369
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity File Number
EntityFileNumber
000-51821
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
LAKE SHORE BANCORP, INC.
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4729288
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
366-4070
CY2020Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Trading Symbol
TradingSymbol
LSBK
CY2019Q1 lsbk Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Earned Shares
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValueEarnedShares
78000
CY2020Q1 lsbk Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Earned Shares
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValueEarnedShares
29000
CY2019Q1 lsbk Compensation Plan Shares Earned
CompensationPlanSharesEarned
5518
CY2020Q1 lsbk Compensation Plan Shares Earned
CompensationPlanSharesEarned
1889
CY2019Q1 lsbk Esop Shares Earned
ESOPSharesEarned
1984
CY2020Q1 lsbk Esop Shares Earned
ESOPSharesEarned
1984
CY2019Q1 lsbk Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
10000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
10676000
CY2020Q1 lsbk Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
13000
CY2020Q1 us-gaap Assets
Assets
628326000
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
71201000
CY2020Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
71112000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1863000
CY2020Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2745000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
134000
CY2020Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
822000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
289000
CY2019Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Before Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeBeforeTax
13000
CY2020Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Before Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeBeforeTax
16000
CY2019Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeTax
-3000
CY2020Q1 lsbk Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeTax
-3000
CY2019Q1 lsbk Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
13000
CY2020Q1 lsbk Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
16000
CY2019Q1 lsbk Right Of Use Asset Recognized
RightOfUseAssetRecognized
904000
CY2019Q1 lsbk Right Of Use Liability Recognized
RightOfUseLiabilityRecognized
916000
CY2020Q1 lsbk Treasury Stock Reissued Average Cost Per Share
TreasuryStockReissuedAverageCostPerShare
9.39
CY2019Q4 lsbk Unearned Esop Shares Cost
UnearnedEsopSharesCost
1364000
CY2020Q1 lsbk Unearned Esop Shares Cost
UnearnedEsopSharesCost
1343000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
79000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
78000
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-13000
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-7000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1331000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2159000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31078000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31105000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000
CY2019Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3233000
CY2020Q1 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
2329000
CY2019Q1 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
75000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
500000
CY2019Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-141000
CY2020Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-138000
CY2019Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
31000
CY2020Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
28000
CY2019Q4 us-gaap Assets
Assets
610869000
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
69472000
CY2020Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
68371000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
130000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
134000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
4000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
11498000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
671000
CY2020Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
6
CY2020Q1 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
3
CY2019Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
21969000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
382000
CY2020Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
22091000
CY2019Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
119000
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
122000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30289000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45539000
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
30289000
CY2020Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
45539000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
7884000
CY2020Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
7912000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30751000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31106000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30289000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45539000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
355000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
15250000
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6836514
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6836514
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5924339
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5918269
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
68000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
68000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1526000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1559000
CY2019Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
39000
CY2020Q1 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
215000
CY2019Q4 us-gaap Deposits
Deposits
483476000
CY2020Q1 us-gaap Deposits
Deposits
501199000
CY2019Q4 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
486487000
CY2020Q1 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
504576000
CY2019Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
198000
CY2020Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
210000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
267000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
259000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.15
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.12
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2019Q1 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
31000
CY2020Q1 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
28000
CY2019Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
36000
CY2020Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
2000
CY2019Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
34650000
CY2020Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
34650000
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2055000
CY2020Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2055000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4267000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4760000
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
10000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
13000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
151000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
6000
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
18000
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
474366000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
166000
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
239000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
465638000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
470636000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
3437000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
3885000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
5897000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3969000
CY2020Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
37000
CY2019 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
491000
CY2019 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
19000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
166000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
166000
CY2019 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
200000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
241000
CY2019 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
10000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
3000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
166000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
239000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
166000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
239000
CY2019 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
291000
CY2019 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
9000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1049000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
853000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122000
CY2019Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
213000
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
67000
CY2019Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-872000
CY2020Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-904000
CY2019Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
8082000
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
17723000
CY2019Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-561000
CY2020Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-353000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
233000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-97000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
8773
CY2019Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
338000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4760000
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
332000
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5662000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6291000
CY2019Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4855000
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5674000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
422247000
CY2020Q1 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
437046000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
22405000
CY2020Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
37627000
CY2019Q1 us-gaap Interest Expense
InterestExpense
1124000
CY2020Q1 us-gaap Interest Expense
InterestExpense
1395000
CY2019Q1 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
972000
CY2020Q1 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
1201000
CY2019Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
133000
CY2020Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
176000
CY2019Q1 us-gaap Interest Expense Other
InterestExpenseOther
19000
CY2020Q1 us-gaap Interest Expense Other
InterestExpenseOther
18000
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4463000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4396000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4538000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4896000
CY2019Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
302000
CY2020Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
262000
CY2019Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
390000
CY2020Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
289000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
1110000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
1396000
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
79000
CY2020Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
78000
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
2153000
CY2020Q1 us-gaap Interest Receivable
InterestReceivable
2220000
CY2019Q4 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
2055000
CY2020Q1 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
2055000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2261000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2216000
CY2019Q4 us-gaap Liabilities
Liabilities
528029000
CY2020Q1 us-gaap Liabilities
Liabilities
544495000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
610869000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
628326000
CY2018Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3448000
CY2019Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3515000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4267000
CY2019Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
3548000
CY2020Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
3509000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
471535000
CY2020Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
474605000
CY2019Q4 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2020Q1 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
470816000
CY2020Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
473354000
CY2019Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
461058000
CY2020Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
475610000
CY2019Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
34658000
CY2020Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
35433000
CY2019Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
158000
CY2020Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
173000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6832000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16183000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6780000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2319000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
303000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1386000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
731000
CY2019Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
-10000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
61229000
CY2020Q1 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
64153000
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
4003000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
3998000
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
589000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
455000
CY2019Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
33000
CY2020Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
23000
CY2019Q1 us-gaap Occupancy Net
OccupancyNet
624000
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
641000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
61950000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
62422000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
421000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
450000
CY2019Q4 us-gaap Other Assets
OtherAssets
2971000
CY2020Q1 us-gaap Other Assets
OtherAssets
2497000
CY2019Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
2153000
CY2020Q1 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
2220000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
808000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
1064000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
638000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
841000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
170000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
223000
CY2019Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
795000
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
1048000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
628000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
828000
CY2019Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
167000
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
220000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
638000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
841000
CY2019Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
115000
CY2020Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
66000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
6670000
CY2020Q1 us-gaap Other Liabilities
OtherLiabilities
6317000
CY2019Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
287000
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
343000
CY2018Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
347000
CY2019Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
334000
CY2019Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
294000
CY2020Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
278000
CY2019Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows
13000
CY2020Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows
16000
CY2019Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
CY2020Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
CY2020Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1666000
CY2019Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
8853000
CY2020Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
3176000
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
111000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
377000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
267000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
259000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1453000
CY2020Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
22000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
86000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
253000
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
750000
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1200000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2159000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2563000
CY2020Q1 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
22000
CY2020Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
1703000
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
234000
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
215000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9415000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9458000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
75000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
500000
CY2019Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
779000
CY2020Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
710000
CY2019Q1 us-gaap Real Estate Acquisitions Through Foreclosures
RealEstateAcquisitionsThroughForeclosures
61000
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
750000
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1200000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
120000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
68000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
79804000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
81062000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
82840000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
83831000
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
5186
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
20830
CY2020Q1 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
20830
CY2019Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
89000
CY2020Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
40000
CY2019Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
60890
CY2020Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
70139
CY2019Q1 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
65000
CY2020Q1 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
76000
CY2019Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
15.14
CY2020Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
14.00
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
912175
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
918245
CY2019Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
7300
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
26900
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10184000
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10365000
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
111000
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
377000
CY2019Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-33000
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-157000
CY2019Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
36000
CY2020Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-36000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt"> <font style="display: inline;font-size:11pt;">To prepare these consolidated financial statements in conformity with GAAP, management of the Company made a number of estimates and assumptions relating to the reporting of assets and liabilities and the reporting of revenue and expenses.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, securities valuation estimates, evaluation of impairment of securities and income taxes.</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6041016
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5986793
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6032243
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5986793

Files In Submission

Name View Source Status
0001341318-20-000038-index-headers.html Edgar Link pending
0001341318-20-000038-index.html Edgar Link pending
0001341318-20-000038.txt Edgar Link pending
0001341318-20-000038-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lsbk-20200331.xml Edgar Link completed
lsbk-20200331.xsd Edgar Link pending
lsbk-20200331x10q.htm Edgar Link pending
lsbk-20200331xex31_1.htm Edgar Link pending
lsbk-20200331xex31_2.htm Edgar Link pending
lsbk-20200331xex32_1.htm Edgar Link pending
lsbk-20200331xex32_2.htm Edgar Link pending
lsbk-20200331_cal.xml Edgar Link unprocessable
lsbk-20200331_def.xml Edgar Link unprocessable
lsbk-20200331_lab.xml Edgar Link unprocessable
lsbk-20200331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending